Picture of ALX Oncology Holdings logo

ALXO — ALX Oncology Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

ALX Oncology Holdings Inc reports results for the quarter ended in March - Earnings Summary

* ALX Oncology Holdings Inc  ALXO.OQ  reported a quarterly
adjusted loss of 71 cents​​ per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of -74 cents.  The mean expectation of six analysts
for the quarter was for a loss of 84 cents per share. Wall
Street expected results to range from -99 cents to -64 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * ALX Oncology Holdings Inc's reported EPS for the quarter
was a
loss of 71 cents​.
    * The company reported a quarterly loss of $35.58 million.
    * ALX Oncology Holdings Inc shares had risen by 49.0% this
quarter and gained 11.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 7.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for ALX Oncology
Holdings Inc is $20.45 
This summary was machine generated from LSEG data May 9 at 09:23
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.84          -0.71          Beat
 Dec. 31 2023      -0.84          -0.93          Missed
 Sep. 30 2023      -0.87          -1.24          Missed
 Jun. 30 2023      -0.88          -0.84          Beat

Recent news on ALX Oncology Holdings

See all news